Therapeutic Hypothermia by Cold Intravenous Fluid and Short Outcome in Asphyxiated Newborn

Document Type : Original Article

Authors

1 Neonatal Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

2 Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

10.22038/ijn.2025.85185.2634

Abstract

Background: Therapeutic hypothermia has reduced mortality and morbidity in asphyxiated newborns. The study aims to induce hypothermia by cold intravenous 10% dextrose and its effect on hospital stay and mortality in asphyxiated newborns..
Methods: Filthy one neonate with asphyxia was randomly assigned to either cold intravenous dextrose 10% for 72 hours started within 6 hours of birth with rectal temperature maintained33-34̊C (no 25 cases) or conventional care (no 26 controls). The primary outcome was hospital stay and death. The optimal rate of rewarming did not exceed the rate of 0.5 ̊C/h. All of them had birth weight ≥ 2500 grams and gestational age ≥ 36 weeks. Those with congenital anomalies, sepsis, DIC, and shock were excluded.
Results: The two groups were the same regarding demographic and obstetric complications. Hospital stays and mortality rates were significantly lower in the case group p-values 0.05 and 0.01, respectively.
Conclusion: Therapeutic hypothermia by cold intravenous dextrose is possible and can reduce hospital stays and mortality with low incomes for asphyxiated newborns.
 
 

Keywords

References

  1. Davidson JO, Wassink G, Van den Heuij LG, Bennet L, Gunn AJ. Therapeutic hypothermia for neonatal hypoxic–ischemic encephalopathy–where to from here? Frontiers in neurology. 2015;6:198.
  2. Gunn AJ, Gunn TR. The 'pharmacology' of neuronal rescue with cerebral hypothermia. Early Hum Dev. 1998;53(1):19-35.
  3. Laptook AR, Shankaran S, Tyson JE, Munoz B, Bell EF, Goldberg RN, et al; Eunice Kennedy shriver national institute of child health and human development neonatal research network. effect of therapeutic hypothermia initiated after 6 hours of age on death or disability among newborns with hypoxic-ischemic encephalopathy: A randomized clinical trial. JAMA. 2017 Oct 24;318(16):1550-1560. 
  4. Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, et al; Eunice Kennedy Shriver NICHD Neonatal Research Network. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med. 2012;366(22): 2085-92. Erratum in: N Engl J Med. 2012; 367(11):1073.
  5. Higgins RD, Raju TN, Perlman J, Azzopardi DV, Blackmon LR, Clark RH, et al. Hypothermia and perinatal asphyxia: executive summary of the National Institute of child health and Human Development workshop. J Pediatr. 2006; 148(2): 170-175.
  6. Bonifacio SL, Saporta A, Glass HC, Lee P, Glidden DV, Ferriero DM, et al. Therapeutic hypothermia for neonatal encephalopathy results in improved microstructure and metabolism in the deep gray nuclei. AJNR Am J Neuroradiol. 2012;33(11):2050-2055. 
  7. Rossouw G, Irlam J, Horn AR. Therapeutic hypothermia for hypoxic ischaemic encephalopathy using low-technology methods: a systematic review and meta-analysis. Acta Paediatr. 2015;104(12): 1217-1228. 
  8. Higgins RD, Raju T, Edwards AD, Azzopardi DV, Bose CL, Clark RH, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Hypothermia Workshop Speakers and Moderators. Hypothermia and other treatment options for neonatal encephalopathy: an executive summary of the Eunice Kennedy Shriver NICHD workshop. J Pediatr. 2011;159(5):851-858.e1.
  9. Jacobs SE, Morley CJ, Inder TE, Stewart MJ, Smith KR, McNamara PJ, et al; Infant Cooling Evaluation Collaboration. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: A randomized controlled trial. Arch Pediatr Adolesc Med. 2011;165(8):692-700.
  10. Takenouchi T, Iwata O, Nabetani M, Tamura M. Therapeutic hypothermia for neonatal encephalopathy: JSPNM & MHLW Japan Working Group Practice Guidelines consensus statement from the working group on therapeutic hypothermia for neonatal encephalopathy, Ministry of Health, Labor and Welfare (MHLW), Japan, and Japan Society for Perinatal and Neonatal Medicine (JSPNM). Brain Dev. 2012;34(2):165-170. 
  11. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al. Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet. 2005;365(9460):663-670. 
  12. Fink EL Kochanek PM, Clark RB, Bell MJ. Fever control and application of hypothermia using intravenous cold saline. Pdiatr Crit Vare Med. 2012;13(1):80-84
  13. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE. A systemic review of the role of intrapartum hypoxic ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol. 2008; 199(6):587-595.
  14. Saeidi, R. Beneficial effects of melatonin for the newborn. Iran J Neonatol. 2024;15(4):1-1.
  15. Saeidi R. Cell therapy in neonates. Iran J Neonatol. 2025; 16(1): 1-2.
  16. Saeidi R. Is neonatal euthanasia and end-of-life morally acceptable? Iran J Neonatol. 2024;15(3):1-2.
  17. Marzban, A., Jafari, N., Zareakbari, M. Serum cardiac troponin i levels in neonates with perinatal asphyxia: A cross-sectional study. Iran J Neonatol. 2025;16(1):19-26.
  18. Kamrani K, Khazraee MS, Zarkesh MR, Moeini R, Shariat M. Can a single value of cardiac troponin i predict short-term adverse outcomes in premature newborns? Iran J Neonatol. 2023;14(1):40-45.   

 

 

Iranian Journal of Neonatology
Volume 16, Issue 2
April 2025
Pages 9-13

Files

Share

How to cite

Statistics